| Original language | English |
|---|---|
| Article number | PCN186 |
| Pages (from-to) | A463-A463 |
| Journal | Value in health |
| Volume | 18 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - Nov 2017 |
| Event | ISPOR 18th Annual European Congress 2015 - MiCo - Milano Congressi, Milan, Italy Duration: 7 Nov 2015 → 11 Nov 2015 Conference number: 18 https://www.ispor.org/event/index/2015milan |
Cite this
Miquel-Cases, A., Steuten, L., & van Harten, W. H. (2017). Cost-effectiveness and feasibility of implementing mri-guided neoadjuvant chemotherapy to treat er-positive her2-negative breast cancers in the Netherlands. Value in health, 18(7), A463-A463. [PCN186]. https://doi.org/10.1016/j.jval.2015.09.1203